Managers / Q4 2022 · view latest →
Crescent Sterling, Ltd.
CIK 0001962005 · 4415 SHORES DRIVE, SUITE 250, METAIRIE, LA, 70006 · 5048851135
Summary
Crescent Sterling, Ltd. reported $93M in U.S.-listed holdings across 66 positions for Q4 2022.
Its largest position, CHV, represents 5.1% of the portfolio.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 83.8% · $78M
- ETP · 13.0% · $12M
- Other · 1.5% · $1M
- ADR · 1.4% · $1M
- REIT · 0.3% · $254,101
Quarter-over-Quarter Changes full breakdown →
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| CHVCHEVRON CORP NEW | NEW | +26.6K | 26.6K | +$5M | $5M |
| JNJJOHNSON & JOHNSON | NEW | +26.9K | 26.9K | +$5M | $5M |
| SCHWAB STRATEGIC TR | NEW | +62.5K | 62.5K | +$5M | $5M |
| AAPLAPPLE INC | NEW | +30.9K | 30.9K | +$4M | $4M |
| CSCOCISCO SYS INC | NEW | +84.1K | 84.1K | +$4M | $4M |
| PGPROCTER AND GAMBLE CO | NEW | +26.2K | 26.2K | +$4M | $4M |
| PEPPEPSICO INC | NEW | +21.3K | 21.3K | +$4M | $4M |
| CVSCVS HEALTH CORP | NEW | +39.6K | 39.6K | +$4M | $4M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q4 2022
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q2 2026 | $112M | 85 | Jul 7, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q1 2026 | $103M | 80 | Apr 7, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $98M | 78 | Jan 7, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $95M | 74 | Oct 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $89M | 72 | Aug 4, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $98M | 75 | Apr 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $97M | 75 | Jan 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $105M | 77 | Oct 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $104M | 77 | Jul 17, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $110M | 80 | Apr 22, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $100M | 76 | Jan 10, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $95M | 72 | Oct 24, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $105M | 78 | Aug 3, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $103M | 74 | Apr 21, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $93M | 66 | Jan 20, 2023 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.